PATENT CLAIM ANALYSIS

Application Number: 16059439
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["424", "078320"]

Abstract:
The present invention is directed to a pharmaceutical composition comprising the compound suvorexant, or a pharmaceutically acceptable salt thereof, a concentration-enhancing polymer, and optionally a pharmaceutically acceptable surfactant.

Claim (Index 11):
The pharmaceutical composition of  claim 10 , wherein the composition optionally comprises one or more surfactants selected from sodium dodecyl sulfate and one or more nonionic surfactants selected from (a) sorbitan fatty acid esters, (b) polyoxyethylene sorbitan fatty acid esters, (c) polyoxyethylene castor oils, (d) polyoxyethylene hydrogenated castor oils, and (e) vitamin E TPGS; and mixtures thereof.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 96.0
- Lexical Diversity: 1.28
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14404147', '15305246', '14002221', '12386402', '11897940']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7386600257227167
- 35 USC 102 Novelty (BERT): 0.5409645552940386
- Combined Prediction Score: 0.718890478679849
- Mean Citation Score: 257.12224
- Max Citation Score: 385.5299
- Similarity Product: 301.0924246613621

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test